New clot drug for heart patients24th May 2012
The National Institute for Health and Clinical Excellence (NICE) has recommended the use of a new type of blood thinning drug for heart patients to cut their risk of stroke.
It says patients with atrial fibrillation (AF), an erratic and sometimes fast heartbeat, can now have rivaroxiban instead of the existing drug warfarin and follows NICE’s recent approval of another drug - dabigatran - for AF. The move has been welcomed by heart experts who say warfarin can be problematic.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: New clot drug for heart patients
Author: Mark Nicholls
Article Id: 21966
Date Added: 24th May 2012